We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles
News

Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles

Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles
News

Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Partek Milestone: Cited in Over 3,000 Peer-reviewed Articles"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Partek Incorporated has reached a milestone by having its software cited in over three thousand peer-reviewed scientific publications including prestigious publications such as New England Journal of Medicine, Cell, and Nature.

On average that is about two citations per business day in the last five years on topics including drug research, human genetics and disease relationships, causes, diagnosis, and treatments. Samples of scientific papers citing the use of Partek software are listed on the Partek website.

When asked the reason so many researchers have used Partek software in their publications, Donald Meyer, COO for Partek, pointed to their long history in the genomics field as well as the ease of use of their software. “Partek software has been used in the Life Sciences for more than 15 years. We are proud that we have been able to assist scientists in their studies of disease and treatments.”

“All of us at Partek get a great deal of satisfaction knowing that the software we create is being used by scientists to advance the health and well-being of people worldwide,” said Tom Downey, CEO of Partek.

Advertisement